• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

脂肪营养不良的诊断策略和临床管理。

Diagnostic strategies and clinical management of lipodystrophy.

机构信息

Division of Metabolism, Endocrinology and Diabetes (MEND), Department of Internal Medicine, Michigan Medicine, University of Michigan, Ann Arbor, MI, USA.

Division of Endocrinology and Metabolism, Department of Internal Medicine, Ribeirao Preto Medical School, Sao Paulo University, Ribeirao Preto, Brazil.

出版信息

Expert Rev Endocrinol Metab. 2020 Mar;15(2):95-114. doi: 10.1080/17446651.2020.1735360.

DOI:10.1080/17446651.2020.1735360
PMID:32368944
Abstract

: Lipodystrophy is a heterogeneous group of rare diseases characterized by various degrees of fat loss which leads to serious morbidity due to metabolic abnormalities associated with insulin resistance and subtype-specific clinical features associated with underlying molecular etiology.: This article aims to help physicians address challenges in diagnosing and managing lipodystrophy. We systematically reviewed the literature on PubMed and Google Scholar databases to summarize the current knowledge in lipodystrophy management.: Adipose tissue is a highly active endocrine organ that regulates metabolic homeostasis in the human body through a comprehensive communication network with other organ systems such as the central nervous system, liver, digestive system, and the immune system. The adipose tissue is capable of producing and secreting numerous factors with important endocrine functions such as leptin that regulates energy homeostasis. Recent developments in the field have helped to solve some of the mysteries behind lipodystrophy that allowed us to get a better understanding of adipocyte function and differentiation. From a clinical standpoint, physicians who suspect lipodystrophy should distinguish the disease from several others that may present with similar clinical features. It is also important for physicians to carefully interpret clinical features, laboratory, and imaging results before moving to more sophisticated tests and making decisions about therapy.

摘要

脂肪营养不良是一组罕见疾病,其特征为不同程度的脂肪丧失,导致代谢异常相关的胰岛素抵抗和与潜在分子病因学相关的亚型特异性临床特征引起严重发病率。本文旨在帮助医生应对脂肪营养不良的诊断和管理挑战。我们系统地回顾了 PubMed 和 Google Scholar 数据库中的文献,以总结脂肪营养不良管理的现有知识。脂肪组织是一个高度活跃的内分泌器官,通过与中枢神经系统、肝脏、消化系统和免疫系统等其他器官系统的全面通讯网络来调节人体的代谢稳态。脂肪组织能够产生和分泌许多具有重要内分泌功能的因子,如调节能量稳态的瘦素。该领域的最新进展有助于解决脂肪营养不良背后的一些谜团,使我们能够更好地理解脂肪细胞的功能和分化。从临床角度来看,怀疑脂肪营养不良的医生应将该疾病与可能具有相似临床特征的其他几种疾病区分开来。医生在进行更复杂的检查和做出治疗决策之前,仔细解释临床特征、实验室和影像学结果也很重要。

相似文献

1
Diagnostic strategies and clinical management of lipodystrophy.脂肪营养不良的诊断策略和临床管理。
Expert Rev Endocrinol Metab. 2020 Mar;15(2):95-114. doi: 10.1080/17446651.2020.1735360.
2
[Lipodystrophy: a new insight into an old disease].[脂肪营养不良:对一种古老疾病的新认识]
Przegl Lek. 2012;69(4):149-56.
3
Diagnosis and treatment of lipodystrophy: a step-by-step approach.脂代谢障碍的诊断与治疗:分步处理。
J Endocrinol Invest. 2019 Jan;42(1):61-73. doi: 10.1007/s40618-018-0887-z. Epub 2018 Apr 27.
4
Practice guideline for lipodystrophy syndromes-clinically important diseases of the Japan Endocrine Society (JES).脂肪营养不良综合征临床实践指南——日本内分泌学会(JES)的重要临床疾病
Endocr J. 2021 Sep 28;68(9):1027-1042. doi: 10.1507/endocrj.EJ21-0110. Epub 2021 Aug 7.
5
Partial lipodystrophy: Clinical presentation and treatment.部分脂肪营养不良:临床表现与治疗。
Ann Endocrinol (Paris). 2024 Jun;85(3):197-200. doi: 10.1016/j.ando.2024.05.015. Epub 2024 Jun 12.
6
Diagnosis, treatment and management of lipodystrophy: the physician perspective on the patient journey.脂代谢障碍的诊断、治疗和管理:从医生角度看患者的就诊历程。
Orphanet J Rare Dis. 2024 Jul 11;19(1):263. doi: 10.1186/s13023-024-03245-3.
7
Molecular and Cellular Bases of Lipodystrophy Syndromes.脂肪营养不良综合征的分子和细胞基础。
Front Endocrinol (Lausanne). 2022 Jan 3;12:803189. doi: 10.3389/fendo.2021.803189. eCollection 2021.
8
Approach to the Patient With Lipodystrophy.脂代谢障碍患者处理方法。
J Clin Endocrinol Metab. 2022 May 17;107(6):1714-1726. doi: 10.1210/clinem/dgac079.
9
Clinical features and metabolic derangements in acquired generalized lipodystrophy: case reports and review of the literature.获得性全身性脂肪营养不良的临床特征与代谢紊乱:病例报告及文献综述
Medicine (Baltimore). 2003 Mar;82(2):129-46. doi: 10.1097/00005792-200303000-00007.
10
Lipodystrophy: Syndrome of severe insulin resistance.脂肪营养不良:严重胰岛素抵抗综合征。
Postgrad Med. 2015 Jun;127(5):511-6. doi: 10.1080/00325481.2015.1015927. Epub 2015 Feb 17.

引用本文的文献

1
Clinical Guidance for Lipodystrophy Syndromes: From Diagnosis and Work-Up to Treatment.脂肪代谢障碍综合征的临床指南:从诊断、检查到治疗
Curr Diab Rep. 2025 Sep 2;25(1):47. doi: 10.1007/s11892-025-01603-4.
2
The clinical approach to child and adolescent patients with lipodystrophy: a series of international case discussions.儿童和青少年脂肪营养不良患者的临床治疗方法:一系列国际病例讨论
Front Endocrinol (Lausanne). 2025 Aug 6;16:1597053. doi: 10.3389/fendo.2025.1597053. eCollection 2025.
3
Lipodystrophy Syndromes: One Name but Many Diseases Highlighting the Importance of Adipose Tissue in Metabolism.
脂肪营养不良综合征:同名却多种疾病,凸显脂肪组织在代谢中的重要性。
Curr Diab Rep. 2025 Aug 21;25(1):46. doi: 10.1007/s11892-025-01602-5.
4
Genetics Evaluation Outcomes From an Academic Multidisciplinary Atypical Diabetes Program.来自学术性多学科非典型糖尿病项目的遗传学评估结果
J Endocr Soc. 2025 Jun 5;9(8):bvaf091. doi: 10.1210/jendso/bvaf091. eCollection 2025 Aug.
5
A real-world pharmacovigilance assessment and literature review of lymphoma development in lipodystrophy.脂肪营养不良中淋巴瘤发生的真实世界药物警戒评估与文献综述
Front Endocrinol (Lausanne). 2025 May 21;16:1582715. doi: 10.3389/fendo.2025.1582715. eCollection 2025.
6
Genomic and Bioinformatics Analysis of Familial Partial Lipodystrophy Type 3 Identified in a Patient with Novel PPARγ Mutation and Robust Response to Pioglitazone.家族性部分性脂肪营养不良 3 型患者的基因组和生物信息学分析:一例新型 PPARγ 突变患者,对吡格列酮反应良好。
Int J Mol Sci. 2024 Nov 10;25(22):12060. doi: 10.3390/ijms252212060.
7
Acquired Partial Lipodystrophy: Clinical Management in a Pregnant Patient.获得性局部脂肪营养不良:一名孕妇的临床管理
J Endocr Soc. 2024 Oct 21;8(12):bvae181. doi: 10.1210/jendso/bvae181. eCollection 2024 Oct 29.
8
Assessment of aortomesenteric distance and mesenteric and retroperitoneal adipose tissue thickness in genetic forms of lipodystrophy.脂肪营养不良遗传形式中主动脉肠系膜距离及肠系膜和腹膜后脂肪组织厚度的评估
J Endocrinol Invest. 2025 Feb;48(2):445-454. doi: 10.1007/s40618-024-02429-9. Epub 2024 Oct 1.
9
Diagnosis, treatment and management of lipodystrophy: the physician perspective on the patient journey.脂代谢障碍的诊断、治疗和管理:从医生角度看患者的就诊历程。
Orphanet J Rare Dis. 2024 Jul 11;19(1):263. doi: 10.1186/s13023-024-03245-3.
10
Early B-cell transcription factor-2 defect as a novel cause of lipodystrophy: disruption of the adipose tissue character and integrity.早期B细胞转录因子2缺陷作为脂肪营养不良的新病因:脂肪组织特征和完整性的破坏
medRxiv. 2024 Jun 24:2024.06.24.24309093. doi: 10.1101/2024.06.24.24309093.